Limin Gu | Medicinal Chemistry | Best Research Article Award

Prof. Dr. Limin Gu | Medicinal Chemistry | Best Research Article Award

Associate Professor | Hebei University of Science and Technology | China

Prof. Dr. Limin Gu is a distinguished Associate Professor and a leading researcher in the field of flame retardant materials and materials science and engineering. She has made significant contributions to advancing sustainable flame-retardant technologies through her work at the College of Chemical and Pharmaceutical Engineering, Hebei University of Science & Technology, and as an active member of the Research Center for Chemical Safety & Security and Verification Technology. Her research focuses on intrinsically flame-retardant polymer synthesis, bio-based halogen-free flame retardants, graphene functionalization, and computer vision-assisted chemical analysis. With strong expertise in analytical techniques such as GC, GC-MS, HPLC, TGA, and TG-IR, she effectively integrates experimental and applied approaches in her studies. Prof. Gu has authored more than 20 scientific publications in prestigious journals including European Polymer Journal, Journal of Thermal Analysis and Calorimetry, and Journal of Applied Polymer Science, and has also published a scholarly monograph on flame-retardant waterborne polyurethane materials. Her innovative research has led to over ten awarded Chinese patents related to bio-based flame retardants, phosphonium compounds, and multifunctional polymeric materials, highlighting her dedication to developing eco-friendly and high-performance flame-retardant systems. Recognized for her scientific excellence and contributions to sustainable materials development, Prof. Gu continues to influence the advancement of green chemistry and polymer innovation. Her growing academic impact is demonstrated by 227 citations, 17 documents, and an h-index of 8, reflecting her emerging leadership and meaningful contributions to the global materials science community.

Profiles : Scopus | ORCID | ResearchGate

Featured Publications

Gu, L., Shi, Y., Liu, W., Zhang, L., & Ge, Y. (2025). Synthesis and characterization of the hemicellulose-based “three sources into one” intumescent flame retardant and its modification on cellulose. Journal of Thermal Analysis and Calorimetry, 150(12), 9105-9119.

Amira Badr | Biochemistry | Best Researcher Award

Prof. Amira Badr | Biochemistry | Best Researcher Award

Professor of Pharmacology and Toxicology, King Saud University, Saudi Arabia.

Dr. Amira Mohammad Abd Elrahim Mohammad Badr is an Associate Professor of Pharmacology and Toxicology at Ain Shams University, Egypt, and King Saud University, Saudi Arabia. She has over two decades of academic and research experience, having made significant contributions to pharmacological and toxicological sciences. Her expertise spans neuropharmacology, cardiovascular pharmacology, environmental toxicology, and chemotherapy-induced organ toxicity. Dr. Badr has published extensively in high-impact journals and participated in numerous national and international conferences. She has supervised several Master’s and PhD theses and served on thesis examination committees. Her academic excellence has earned her recognition among the world’s top 2% scientists by Stanford University. She is also actively involved in curriculum development, quality assurance, and faculty training programs. In addition to her academic achievements, Dr. Badr has contributed to peer review processes and editorial roles in prestigious journals. Her research continues to impact both scientific knowledge and public health policy.

Professional Profile 

Dr. Amira Badr holds a distinguished academic record in pharmaceutical sciences from Ain Shams University, Cairo, Egypt. She earned her Ph.D. in Pharmaceutical Sciences with a thesis focusing on the pharmacological outcomes of carvedilol and carnitine in treating myocardial infarction in rats. This was preceded by a Master’s degree, where she investigated the hepatoprotective effects of natural products. Her undergraduate education culminated in a Bachelor of Science in Pharmaceutical Sciences , where she graduated with top honors, ranking first among her peers. Throughout her academic journey, Dr. Badr has demonstrated consistent academic excellence, producing impactful research that led to journal publications at each level of study. Her educational background laid a solid foundation for her specialization in pharmacology and toxicology and provided her with critical analytical and experimental skills. These have fueled her passion for academic teaching, mentoring, and cutting-edge biomedical research over the years.

Experience 

Dr. Amira Badr possesses over 20 years of academic experience in pharmacology and toxicology. Her career began  as an instructor at Ain Shams University, followed by roles as an assistant lecturer and lecturer.  she transitioned to King Saud University, where she progressed from Assistant to Associate Professor. Parallel to her roles in Saudi Arabia, she maintained affiliations with Ain Shams University, reflecting her dual academic presence. Dr. Badr has taught numerous undergraduate and postgraduate courses in pharmacology, toxicology, and biochemistry. Her extensive teaching includes advanced topics such as neuropharmacology, pharmacogenomics, and industrial toxicology. She also served as a mentor for numerous graduation projects and supervised multiple Master’s theses. In addition to teaching, she has been involved in quality assurance, scientific committees, and student evaluation processes. Her multifaceted experience spans research leadership, academic governance, and scientific mentorship, demonstrating her deep commitment to both education and biomedical research.

Professional Development

Dr. Amira Badr has pursued comprehensive professional development, undertaking over 25 training courses spanning teaching methodologies, research ethics, scientific writing, technology in education, and leadership. At Ain Shams University, she completed programs on communication skills, teaching effectiveness, research methods, and exam evaluation. Later, she expanded her expertise through advanced courses in e-learning, stress management, sustainable development, and conference organization. At King Saud University, she undertook specialized training in microteaching, capstone course design, and digital tools such as Blackboard, EndNote, and Photoshop. She also completed training in project management and program learning outcome assessments, aligning her work with modern academic standards and national qualification frameworks. Her role as a trainer for new academic staff further illustrates her leadership in academic capacity building. These continued development efforts reflect her dedication to remaining at the forefront of academic excellence and innovation, enhancing both her teaching capabilities and research supervision effectiveness in a dynamic educational environment.

Skills & Expertise

Dr. Amira Badr brings a diverse skill set that spans research, teaching, leadership, and scientific communication. Her core competencies include experimental pharmacology, toxicological assessments, molecular biology techniques, and preclinical models of organ toxicity. She is adept at teaching undergraduate and postgraduate courses, having developed and delivered curricula in basic and advanced pharmacology, clinical toxicology, and pharmacogenomics. She is proficient in scientific writing, manuscript editing, and supervising graduate research, with many students successfully completing their theses under her guidance. Her technical capabilities include using academic platforms like Blackboard, EndNote, and CourseLab. Dr. Badr also demonstrates strong administrative and organizational skills, evident from her roles in academic committees, quality assurance, and faculty training. Her participation in workshops on leadership, time management, digital tools, and e-learning reflects a continuous drive for self-improvement. Her combination of scientific acumen, teaching excellence, and project leadership make her a well-rounded and highly effective academic professional.

Resarch Focus

Dr. Amira Badr’s research is centered on pharmacology and toxicology, with a specialized focus on organ protection from chemotherapy-induced damage, neuropharmacology, cardiovascular pharmacology, and metabolic disorders such as non-alcoholic fatty liver disease. She investigates protective mechanisms of natural compounds and pharmacological agents against oxidative stress, inflammation, and apoptosis in preclinical models. Her research integrates molecular pharmacology, pathophysiology, and experimental toxicology, particularly emphasizing the modulation of signaling pathways like TLR4/NF-κB, Notch, and SIRT1/Nrf2 in disease progression and drug response. She is also engaged in environmental toxicology, exploring the effects of pollutants such as microplastics and heavy metals on organ systems. Her translational approach aims to bridge bench-side discoveries with therapeutic potential. Notably, her recent work has explored drug delivery systems, phytotherapy, and molecular targets in cancer and kidney diseases. Dr. Badr’s holistic and multidisciplinary research positions her at the forefront of pharmacological innovation aimed at safer, more effective therapeutic strategies.

Awards & Recognitions

Dr. Amira Badr has earned notable recognition throughout her academic career. Most prominently, she has been included in Stanford University’s global list of the top 2% of scientists  based on Scopus-indexed data, reflecting her influential contributions to pharmacology and toxicology. With over 1088 citations and an h-index of 16 (Google Scholar), she has demonstrated consistent scholarly impact. She has served as the principal investigator of a research group funded by the Deanship of Scientific Research at King Saud University. Additionally, she holds the position of Academic Editor at Oxidative Medicine and Cellular Longevity and has reviewed over 40 manuscripts for top-tier ISI journals. Her extensive involvement in academic committees, research days, and scientific poster and oral presentations further underscores her leadership and commitment to scientific advancement. These honors validate her reputation as an accomplished researcher and educator in her field, both nationally and internationally.

Publication Top Notes 

Conclusion:

Dr. Amira Badr’s extensive research contributions, recognized scientific impact, and leadership in toxicology and pharmacology make her an outstanding contender for the Best Researcher Award. Her profile aligns strongly with the award’s core criteria: research excellence, originality, societal impact, and mentorship. With continued international collaboration and translational focus, she is poised to make even greater global contributions to biomedical science.

Abdelhadi Boussena | Molecular Biology | Best Researcher Award

Dr. Abdelhadi Boussena | Molecular Biology | Best Researcher Award

chlef university , Algeria.

🔬 Short Biography 🌿💊📚

Abdelhadi Boussena 🎓 is a dedicated microbiologist 🧫 from Algeria 🇩🇿 with a passion for scientific research and academic development. Holding a Ph.D. in Microbiology from Abdelhamid Ibn Badis University, Mostaganem, he has built his expertise in parasitology, microbial ecology, and antibacterial properties of medicinal plants 🌿. His academic path reflects consistent excellence, starting with a Bachelor’s and Master’s in Microbiology from Hassiba Ben Bouali University, Chlef. Professionally, he has served as a pharmacy assistant and contributed to the academic community through student supervision and course instruction 🧑‍🏫. Boussena has published and presented multiple research studies focusing on antibacterial and antioxidant properties of natural extracts 🧪. Fluent in Arabic and competent in French 🇫🇷 and English 🇬🇧, he combines solid communication skills with a calm and problem-solving approach. His ambition is to continue expanding knowledge in microbiology and contribute to global scientific advancement 🌍.

PROFILE 

ORCID 

🔍 Summary of Suitability:

Dr. Abdelhadi Boussena demonstrates a clear and consistent dedication to microbiological research, particularly in the exploration of bioactive compounds from medicinal plants 🌿. His work targets globally significant challenges such as antibiotic resistance, biofilm inhibition, and natural antioxidant discovery, aligning closely with public health priorities and sustainable scientific innovation 🌍. Through his publications, participation in international symposia, and academic involvement in student mentorship and teaching 🧑‍🏫, he exemplifies qualities of a committed and impactful researcher.

📘 Education & Experience

Education:

  • 📚 Ph.D. in Microbiology – Abdelhamid Ibn Badis University, Mostaganem (2019)

  • 📘 Master of Science in Microbiology – Hassiba Ben Bouali University, Chlef

  • 🧬 Bachelor of Science in Parasitology and Microbiology – Hassiba Ben Bouali University, Chlef

Experience:

  • 💊 Pharmacy Assistant – Chlef, Algeria (2016–2017)

  • 🧑‍🏫 Teaching in microbial ecology & systematics (2022)

  • 🧑‍🎓 Co-supervised Master’s students (2019–2022)

  • 🌿 Researcher in medicinal plant valorization

Professional Development 🚀📖

Abdelhadi Boussena’s career reflects a strong commitment to continuous professional development and academic excellence 📖. He actively engages in research focused on microbiological applications of medicinal plants 🌱, exploring their antibacterial and antioxidant properties. His teaching role includes guiding students in microbial ecology and systematics 🧫, demonstrating both pedagogical skills and scientific depth. Boussena has presented at multiple national and international symposia 🎤, broadening his academic network and knowledge base. He has authored peer-reviewed articles on topics such as the phytochemical properties of Ephedra alata and Haloxylon scoparium 📄. His work aims to combat multidrug-resistant pathogens, contributing to public health and environmental sustainability 🧬🌍. Through collaboration, publications, and supervision, he demonstrates leadership and mentorship. His ability to adapt to new scientific methods and share knowledge makes him an asset in microbiology and natural product research 💡.

Research Focus 🔍🤖

Dr. Abdelhadi Boussena’s research centers on the microbiological evaluation of medicinal plants 🌿 for their therapeutic potential against resistant bacterial strains 🦠. His work integrates phytochemical screening, antibacterial and antioxidant assays to identify bioactive compounds from Algerian flora such as Ephedra alata and Haloxylon scoparium 🌵. This research plays a pivotal role in addressing global health concerns related to antibiotic resistance 🧫. He is particularly interested in nosocomial pathogens and biofilm-forming bacteria like Staphylococcus aureus and Pseudomonas aeruginosa 🧪. His methods include agar dilution and phenolic content analysis to evaluate extract potency. Boussena also explores the ecological and sustainable development implications of his findings 🌎. His work contributes to green chemistry and integrative medicine, positioning him at the intersection of environmental microbiology, pharmacognosy, and public health 💊. Through experimentation and collaboration, his ultimate goal is to harness nature’s pharmacy for modern therapeutic solutions.

Awards and Honors 🏆🎖️

  • 🏆 Participant – First National Seminar on Nutrition and Health

  • 🥇 Presenter – 1st International Symposium on Environment & Sustainable Development

  • 🧪 Speaker – National Seminar on Biodiversity of Fauna and Flora in Algeria (2022)

  • 📄 Published – International Journal of Human Settlements (Antibiofilm Study)

  • 📘 Published – Journal of Applied Biological Sciences (Phytochemical Analysis)

Publications & Citations 📚

📘 “Evaluation of the antioxidant activity of the hydro-methanolic extract of Ephedra alata (Ephedraceae)” – Published: 2020 📅 | Citation info: Not listed 📉 | 🧪🌿🧫

📘 “Activité antibactérienne des deux extraits d’Ephedra alata sur une bactérie entérique à Gram négatif…” – Published: 2021 📅 | Citation info: Not listed 📉 | 🦠🔬🌱

📘 “Activités antibactériennes et antibiofilms des souches de lactobacilles vis-à-vis Staphylococcus aureus, Pseudomonas aeruginosa, Bacillus subtilis, B. cereus – Published in International Journal of Human Settlements, Year: Unknown 📅 | Citation info: Not listed 📉 | 🧫🧪🧬

📘 “Phytochemical screening, phenolic content and antioxidant activity of Haloxylon scoparium – Published: 2022 📅 | Citation info: Not listed 📉 | 🌿🧪🧬

📘 “Screening of phytochemicals, evaluation of phenolic content, antibacterial and antioxidant activities of Ephedra alata from Algerian Sahara” – Published: 2022 📅 | Citation info: Not listed 📉 | 🌵🧪🔬

📘 “Use of Haloxylon scoparium Against Multidrug-Resistant Bacteria from Urinary Tract Infections” – Published: Unknown 📅 | Citation info: Not listed 📉 | 💊🦠🌱

🔍 Conclusion:

Dr. Abdelhadi Boussena’s research is both scientifically relevant and socially impactful, addressing critical issues in antimicrobial resistance through eco-conscious methods. His proactive involvement in academia and sustained research output make him highly suitable for recognition through a Best Researcher Award. His work bridges microbiology and pharmacognosy, fostering innovation and contributing to the global effort for sustainable and effective health solutions. 🏆

 

 

 

Shuanglin Qin | Chemical Biology | Best Researcher Award

Prof. Shuanglin Qin | Chemical Biology | Best Researcher Award

Professor at Hunan University of Chinese Medicine , China.

Professor Shuanglin Qin 👨‍🔬, born on October 1, 1989 🎂, is a prominent researcher at the Research Center for Precision Medication of Chinese Medicine, Hunan University of Chinese Medicine 🏫. With a Ph.D. in Chemical Biology 🎓, his research focuses on anti-cancer drug discovery and traditional Chinese medicinal compounds 💊🌿. Known for his excellence in natural product-based drug development, he has earned notable accolades such as the Hunan Distinguished Young Scholars award 🏅. Prof. Qin also serves as an editorial member for prestigious journals 📚 and actively contributes to advancing chemical biology and precision medicine 🔬✨.

PROFILE 

ORCID 

SCOPUS 

🔍 Summary of Suitability:

Professor Shuanglin Qin demonstrates exceptional research caliber, leadership, and consistent scholarly impact in the fields of chemical biology and anti-cancer drug discovery. His academic journey reflects steady growth from student to professor, with groundbreaking work in natural product-based therapeutics rooted in Traditional Chinese Medicine 🌿. He has earned competitive national and provincial funding, secured editorial roles in top-tier journals, and actively contributed to the peer-review ecosystem of global scientific publications 🌍📚. These achievements mark him as a leader in his field and an ideal candidate for the Best Researcher Award.

🎓 Education & 🧪 Experience 

🎓 Education:

  • 📍 2016–2019: Ph.D., School of Pharmaceutical Science and Technology, Tianjin University

  • 📍 2013–2016: Master’s, School of Pharmacy, Jiangxi Science & Technology Normal University

  • 📍 2009–2013: Bachelor’s, School of Pharmacy, Hunan University of Chinese Medicine

🧪 Experience:

  • 🧑‍🏫 2024–2025: Professor, Hunan University of Chinese Medicine

  • 🧑‍🏫 2019–2024: Associate Professor, Hubei University of Science and Technology

Professional Development 🚀📖

Professor Shuanglin Qin is committed to continual professional advancement 🌟. As a principal investigator, he has led numerous high-impact projects under national and provincial funding programs, including the National Natural Science Foundation of China 💼🔬. He actively collaborates across disciplines to explore mechanisms of natural product-derived drugs. His editorial contributions span journals like the Journal of Oncology and Traditional Medicine Research 📝📊. As a peer reviewer for renowned scientific outlets, he ensures the integrity of research dissemination 🔍. His work fosters innovation in traditional Chinese medicine and strengthens links between academia and healthcare industries globally 🌍🧠.

Research Focus 🔍🤖

Professor Qin’s research primarily focuses on chemical biology and anti-cancer drug discovery 🧪🧬. He explores the molecular mechanisms of action and therapeutic potentials of natural products derived from traditional Chinese medicine 🌿💊. His interdisciplinary approach combines pharmacology, biochemistry, and medicinal chemistry to identify novel bioactive compounds targeting tumors 🎯. His efforts are directed toward developing precision medications with high efficacy and minimal side effects 🧠⚕️. By bridging modern technology with ancient remedies, his research significantly advances cancer therapeutics and natural product innovation 🔄🌱. His lab continues to pave the way in translational cancer research and drug development 🚀.

Awards and Honors 🏆🎖️

  • 🥇 Winner, Hunan Science Fund for Distinguished Young Scholars

  • 🏅 Winner, ChuTian Scholars Program, Hubei Province

  • 📊 Principal Investigator, National Natural Science Foundation of China projects

  • 🧪 Recipient, China Postdoctoral Science Foundation funding

  • 📘 Recognized in Youth Talent Programs by Hubei Health Commission & Education Department

  • 📝 Editorial roles in Journal of Oncology, Traditional Medicine Research, Life Research, and Medical Data Mining

  • 🔍 Reviewer for journals like European Journal of Medicinal Chemistry and Frontiers in Cell and Developmental Biology

Publications & Citations 📚

  • 📊 “Integrated evidence chain-based effectiveness evaluation of traditional Chinese medicines (Eff-iEC): A demonstration study” – Ye Luo et al., Acta Pharmaceutica Sinica B, 2025 | 📅 2025 | 📑 Cited by: 1

  • 🧬 “PROTACs coupled with oligonucleotides to tackle the undruggable” – Guangshuai Zhang et al., Journal not specified, 2025 | 📅 2025 | 📑 Cited by: 0

  • 🌿 “Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation” – Xingyun Liu et al., BMC Complementary Medicine and Therapies, 2024 | 📅 2024 | 📑 Cited by: 2

  • 🔬 “PROTAC technology: From drug development to probe technology for target deconvolution” – Si Yan et al., Journal not specified, 2025 | 📅 2025 | 📑 Cited by: 19

🔍 Conclusion:

Professor Qin’s dedication to translational cancer research, deep-rooted knowledge in natural product chemistry, and outstanding scientific contributions make him a model researcher in his domain. His influence spans innovation, education, and publication, fulfilling the highest standards for a Best Researcher Award recipient. He exemplifies not just academic productivity, but also real-world impact in advancing healthcare through traditional knowledge and modern science fusion.

 

 

SUNRAY LEE | Molecular Biology | Best Researcher Award

Ms. SUNRAY LEE | Molecular Biology | Best Researcher Award

Research Director at CEFObio Co., Ltd , South Korea.

Dr. Sunray Lee is a distinguished researcher and Director of CEFO Research Institute in Seoul, Korea 🇰🇷. With a Ph.D. in Stem Cell Biology from Korea University 🎓, his expertise spans molecular immunology, MHC biology, and regenerative medicine 🧬. Over two decades, he has led pivotal R&D in stem cells, biomaterials, and cell therapy 🧪. As a prolific author and patent holder, Dr. Lee’s innovations have influenced cosmetic biotechnology, bone regeneration, and 3D cell culture 🌿🧫. He is a regular member of national innovation committees and an active contributor to international conferences and regenerative medicine networks 🌍.

PROFILE 

orcid

🔍 Summary of Suitability:

Dr. Sunray Lee embodies the ideal candidate for a Best Researcher Award through his unmatched dedication, multidisciplinary expertise, and leadership in regenerative medicine, stem cell biology, and biomaterials research. With over 20 years of experience and numerous high-impact publications, his work bridges science and innovation, directly contributing to advancements in clinical and cosmetic therapeutics. He has led transformative R&D, mentored scientific communities, and represented Korea in international regenerative medicine collaborations.

🎓 Education

  • B.Sc. in Agronomy – Korea University (1995–1999) 🌾

  • M.Sc. in Molecular & Cellular Immunology – Korea University (2000–2003) 🧫

  • Ph.D. in MHC & Stem Cell Biology – Korea University (2006–2012) 🧬

💼 Professional Experience

  • 🔬 Researcher, MHC Lab, Seoul National University (2004–2005)

  • 🧪 Senior Scientist, MizMedi Hospital (2005–2007)

  • 🧫 Senior Scientist, MCTT Research Institute (2007–2011)

  • 🧠 Member, KEIT Innovation Evaluation (2010–2025)

  • 🧬 Director, CEFO Research Institute (2012–Present)

  • 🔗 Committee Member, KSMCB, KSB, KSSCR, CARM, APACRM (2017–Present)

Professional Development 🚀📖

Dr. Sunray Lee’s professional growth is rooted in cross-disciplinary research, collaborative leadership, and regulatory insight 📚🔬. He is deeply involved in Korea’s R&D planning and policy through KEIT and serves as Vice Chair at CARM’s International Cooperation Committee 🌐🤝. His participation in global forums like APACRM and KSSCR highlights his dedication to regenerative medicine diplomacy 🌱💬. Dr. Lee frequently delivers keynote talks and publishes cutting-edge research in journals spanning biomedical engineering, dermatology, and pharmaceuticals 📖🗣️. He continuously fosters innovation through industry-academia linkages and promotes ethical advancement in biotechnology and stem cell research 🌍⚙️.

Research Focus 🔍🤖

Dr. Lee’s research revolves around regenerative medicine, focusing on stem cell biology, biomaterials, and cellular therapy 🧬🧪. His work includes developing 3D cell culture systems, cryopreservation methods, and stem cell-based skin and bone therapies 🧫🦴. A major emphasis lies in mesenchymal stem cells, pluripotent stem cells, and their therapeutic applications in cosmetics and orthopedics 🧖‍♀️⚕️. His projects combine bioengineering, molecular biology, and omics to optimize cell culture environments and develop innovative treatment platforms 🔍🔧. With a vision toward translational medicine, he contributes to national and international standards for advanced regenerative products and clinical protocols 🌐🧠.

Awards and Honors 🏆🎖️

  • 🏅 Citation by Ministry of Trade, Industry & Energy (MOTIE) – Dec. 12, 2018

  • 🥇 Best Investigator Award, Korea University – Mar. 27, 2012

Publications & Citations 📚

    • 2025 – 🧪 Development of Mold Technology for Insert-Wells

    • 2024 – 🧬 Cell Therapy Using Umbilical Cord MSCs for Osteonecrosis

    • 2023 – 🦴 Osteogenic-Induced Adipose Stem Cells in Canine Bone Repair

    • 2023 – 💧 Stem Cell-Conditioned Medium for Whitening & Moisturizing

    • 2023 – 🧫 Tracking HUVECs Using Quantum Dot Nanoparticles

    • 2023 – 🌏 Asia Guidelines for Ancillary Materials in Cell Therapy

    • 2022 – ❄️ Cryogenic Storage Container Cell Viability Study

    • 2022 – 💆 3D Stem Cell Cream Effects on Skin Elasticity

    • 2020 – 🌿 Anti-aging Effects of Stem Cell Creams

    • 2020 – 🧬 Medroxyprogesterone & Metformin in Endometrial Cancer

    • 2020 – ❄️ Cryogenic Container Plastic Changes Analysis

    • 2020 – 💊 3D Co-culture to Enhance Drug Selectivity

    • 2020 – 🧴 Cosmetic Products with MSC Medium

    • 2019 – 🐎 Equine iPSCs for Therapeutic MSC Differentiation

    • 2019 – 🛡️ Immune Effects of 3D MSC Conditioned Cream

    • 2018 – 💪 Induced Myogenic Stem Cells via Transcription Factors

    • 2016 – 💉 Apoptin Gene Delivery for Glioma Cells

    • 2016 – 🧬 Glycol Chitosan-PEI Gene Carrier for MSCs

    • 2016 – 🧫 PAMAM Dendrimers for Gene Delivery to MSCs

    • 2012 – 🧬 DNA Methylation in Pluripotent Stem Cells

    • 2011 – 🧪 Stem Cell Substrate Physical Properties

    • 2011 – 🦷 Dental Stem Cell Comparisons

    • 2011 – 🔁 Dynamic Gene Copy Number Changes in iPSCs

    • 2010 – 🧬 Adipogenic Differentiation in Feeder Cells

    • 2010 – 🧬 Umbilical MSCs as Therapy

    • 2009 – 🦴 MSC Source Phenotypic Analysi

    • 2004 – ⚙️ Promyelocytic Leukemia & SAPK2 Inhibition

    • 2004 – 🦠 CMV and MHC Class I Immune Evasion

    • 2004 – 🛡️ HLA-G Shedding & NK Cell Inhibition

 🔍 Conclusion:

Dr. Sunray Lee’s consistent pursuit of excellence, coupled with tangible contributions to science, medicine, and technology, makes him not just a candidate—but a model recipient—for the Best Researcher Award. His innovative mindset, translational achievements, and leadership in stem cell applications mark him as a cornerstone in modern biomedical research 🧠🌱.

 

 

Seohee Han | Biochemistry | Best Researcher Award

Mr. Seohee Han | Biochemistry | Best Researcher Award

Master’s degree student at Inje University in South Korea.

 

Han Seohee 👨‍🔬, a 26-year-old master’s student at Inje University 🎓, is a rising talent in the field of biomedical engineering and healthcare IT 💡. Specializing in Organ-on-a-Chip, Eye-on-a-Chip, and microfluidics 💧, he actively contributes to innovative research at the BioMEMS Lab 🔬. His expertise spans PDMS chip fabrication, TEER testing, drug screening 💊, and smart manufacturing using 3D printing 🖨️. With strong skills in AutoCAD, SolidWorks, and Fusion360 📐, Han Seohee is leading advancements in disease modeling and anti-aging healthcare technologies 👁️🧠. He is expected to graduate in August 2025 and continues to shape the future of medical research 🚀

Professional Profile

Orcid 

🔍 Summary of Suitability:

Han Seohee, a master’s student at Inje University specializing in biomedical engineering and healthcare IT, has demonstrated exceptional dedication to interdisciplinary research in organ-on-a-chip, eye-on-a-chip, bio-MEMS, and drug screening technologies. As a researcher at the BioMEMS Lab, his expertise spans PDMS chip fabrication, semiconductor processes (Su-8), TEER testing, and CAD-based microdevice design. He has actively contributed to innovative healthcare platforms, organoid-based disease models, and next-gen smart manufacturing systems.

🎓 Education

  • 📍 Inje University, Graduate School (2023 – Aug 2025, expected)

    • Master’s degree in Digital Anti-Aging Healthcare & Convergence Biomedical Engineering

    • Focus: Organ-on-a-Chip, BioMEMS, Microfluidics, Smart Healthcare IT

  • 📍 Inje University, Undergraduate (Completed)

    • Major in Biomedical Engineering

    • Strong foundation in medical devices, biosignals, and human physiology

🧪 Research Experience

  • 🧬 Researcher at BioMEMS Lab, Inje University

    • Working on Organ-on-a-Chip and Eye-on-a-Chip platforms

    • Developing PDMS-based microfluidic chips using SU-8 photolithography

  • 🧠 Participated in a project on depression treatment using brain organoid-on-a-chip

    • Drug efficacy testing using 3D tissue models

    • Integration of pharmacological data with bio-sensing technologies

  • 👁️ Led research on artificial eye models for vision diagnostics and smart device integration

    • Included lens design, curvature simulation, and 3D prototyping

  • 🧫 Conducted TEER (Transepithelial Electrical Resistance) measurements for barrier integrity testing in microfluidic platforms

  • 🛠️ Experience in smart manufacturing and 3D printing for biomedical applications

    • Designed parts using AutoCAD, SolidWorks, and Fusion360

  • 💊 Involved in new drug development and screening systems using organ-on-chip models

    • Mimicked physiological conditions for more accurate in-vitro analysis

Professional Development 🚀📖

🧠 Han Seohee has actively pursued professional growth through interdisciplinary research in biomedical engineering and healthcare IT. 💡 He developed expertise in Organ-on-a-Chip 🧬, Eye-on-a-Chip 👁️, and microfluidic systems using PDMS and SU-8 fabrication. 🔬 He sharpened his skills in 3D printing 🖨️, lens design 🛠️, and CAD software like AutoCAD and SolidWorks. 💊 Through drug screening, TEER testing ⚡, and organoid modeling, he deepened his understanding of pharmacological evaluation and disease mechanisms. 🧪 His active role in BioMEMS Lab research and smart healthcare projects demonstrates his commitment to innovation 🌐 and advancing next-generation biomedical solutions. 🚀

Research Focus 🔍🤖

🔬 Han Seohee’s research focuses on Biomedical Engineering and Healthcare IT Convergence 🧠, particularly in the development of advanced organ-on-a-chip platforms 🧬 like Eye-on-a-Chip 👁️. His work integrates microfluidics 💧, bio-MEMS technologies ⚙️, and semiconductor processes like SU-8 fabrication 🧱 to simulate human organ functions for drug screening 💊 and disease modeling 🧪. He contributes to projects involving smart manufacturing platforms 🖨️, artificial eye models, and anti-aging healthcare 🧓🏻➡️🧑🏻. His interdisciplinary approach bridges biomedical science, engineering, and digital healthcare innovation 🌐, pushing the boundaries of next-gen medical testing and personalized medicine 🧫.

🏆 Awards & Honors:

🏅 Best Poster Award – Recognized for presenting outstanding research on Eye-on-a-Chip at an academic conference.
🎖️ Research Excellence Grant Recipient – Awarded for high-impact work in biomedical engineering and drug screening.
🏆 Innovation in Smart Healthcare Award – Honored for contributions to anti-aging healthcare technology platforms.
📜 Academic Scholarship – Received competitive funding during graduate studies for academic excellence.
🔬 Top Young Researcher Recognition – Acknowledged for interdisciplinary work in organoid-on-a-chip and digital healthcare convergence.
👨‍🔬 Lab Leadership Recognition – Commended by BioMEMS Lab for contributions to research direction and project outcomes.

Publications & Citations 📚

📄 “Comparison of Wound Healing Effects of Different Micro-Patterned Hydrogels on the Skin of Secondary Intention Rat Model”Gels, 2025 | ✍️ Author: Han Seohee | 🔗 DOI: 10.3390/gels11040239 | 📅 Published: 2025 | 👥 Cited by: 0 (as of now) | 🧪 #WoundHealing #Hydrogels #Bioengineering

🔍 Conclusion:

Han Seohee exemplifies the spirit of next-generation biomedical innovation. His cross-disciplinary knowledge, practical lab experience, and future-focused research projects make him a strong contender for the Best Researcher Award. His work has the potential to revolutionize personalized medicine, disease diagnostics, and smart therapeutics, reflecting both academic excellence and real-world impact. 🌐🔬💡